Refine
Year of publication
Document Type
- Article (30556)
- Part of Periodical (11484)
- Book (8241)
- Doctoral Thesis (5614)
- Part of a Book (3882)
- Working Paper (3370)
- Review (2922)
- Contribution to a Periodical (2306)
- Preprint (1842)
- Report (1561)
Language
- German (42323)
- English (28397)
- French (1060)
- Portuguese (840)
- Spanish (309)
- Croatian (302)
- Multiple languages (255)
- Italian (197)
- mis (174)
- Turkish (168)
Has Fulltext
- yes (74349) (remove)
Keywords
- Deutsch (1076)
- Literatur (858)
- taxonomy (741)
- Deutschland (551)
- Rezension (511)
- new species (439)
- Rezeption (350)
- Frankfurt <Main> / Universität (341)
- Übersetzung (315)
- Geschichte (299)
Institute
- Medizin (7392)
- Präsidium (5097)
- Physik (4140)
- Extern (2738)
- Wirtschaftswissenschaften (2648)
- Gesellschaftswissenschaften (2362)
- Biowissenschaften (2128)
- Biochemie und Chemie (1961)
- Center for Financial Studies (CFS) (1608)
- Informatik (1577)
BACKGROUND: Transient episodes of ischemia in a remote organ or tissue (remote ischemic preconditioning, RIPC) can attenuate myocardial injury. Myocardial damage is associated with tissue remodeling and the matrix metalloproteinases 2 and 9 (MMP-2/9) are crucially involved in these events. Here we investigated the effects of RIPC on the activities of heart tissue MMP-2/9 and their correlation with serum concentrations of cardiac troponin T (cTnT), a marker for myocardial damage.
METHODS: In cardiosurgical patients with cardiopulmonary bypass (CPB) RIPC was induced by four 5 minute cycles of upper limb ischemia/reperfusion. Cardiac tissue was obtained before as well as after CPB and serum cTnT concentrations were measured. Tissue derived from control patients (N = 17) with high cTnT concentrations (≥0.32 ng/ml) and RIPC patients (N = 18) with low cTnT (≤0.32 ng/ml) was subjected to gelatin zymography to quantify MMP-2/9 activities.
RESULTS: In cardiac biopsies obtained before CPB, activities of MMP-2/9 were attenuated in the RIPC group (MMP-2: Control, 1.13 ± 0.13 a.u.; RIPC, 0.71 ± 0.12 a.u.; P < 0.05. MMP-9: Control, 1.50 ± 0.16 a.u.; RIPC, 0.87 ± 0.14 a.u.; P < 0.01), while activities of the pro-MMPs were not altered (P > 0.05). In cardiac biopsies taken after CPB activities of pro- and active MMP-2/9 were not different between the groups (P > 0.05). Spearman's rank tests showed that MMP-2/9 activities in cardiac tissue obtained before CPB were positively correlated with postoperative cTnT serum levels (MMP-2, P = 0.016; MMP-9, P = 0.015).
CONCLUSIONS: Activities of MMP-2/9 in cardiac tissue obtained before CPB are attenuated by RIPC and are positively correlated with serum concentrations of cTnT. MMPs may represent potential targets for RIPC mediated cardioprotection.
TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT00877305.